Science Philanthropy Accelerator for Research and Collaboration (SPARC)

Image
Light-skinned female-presenting person named Caitlyn Barrett with light hair in a yellow jacket and black shirt with gray gradient background

Caitlyn Barrett, PhD

Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic Philanthropy
Caitlyn Barrett, PhD, is a director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. Her scientific expertise in cancer biology and neurodegeneration in addition to her experience in grant and program management, stakeholder engagement, and program analysis are brought to bear as she partners with philanthropists to maximize their impact on the biomedical ecosystem.
Image
A smiling dark-skinned man named Quinton Banks with short dark braided hair, wearing glasses and a navy blue patterned dress shirt, and standing in a room with dark wood details.

Quinton Banks, PhD

Associate Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic Philanthropy
Quinton Banks,PhD, is an associate director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. His extensive scientific background includes research into chronic pain, taste perception, and muscle physiology.
Image
A smiling female-presenting person named Veronica Beck with shoulder-length brown hair and white skin against a blurred background, wearing a black shirt.

Veronica Beck

Associate Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic Philanthropy
Veronica Beck is an associate director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. She uses her expertise to identify and implement innovative biomedical research ideas, partnering with philanthropists and key field leaders to ensure promising research projects receive the necessary support to become impactful therapies.